Posterizan (microbial cells of Escherichia coli) suppositories №10

$52.00

Purpose: Disrupts bacterial cells to treat gastrointestinal infections.

SKU: MED60632 Category:

Description

Posterizan (microbial cells of Escherichia coli) suppositories №10

Ingredients

Active ingredient: Microbial cells of Escherichia coli.

Dosage

Adults and children over 14 years: Insert 1 suppository into the rectum twice daily for 7 days.

Indications

Posterizan suppositories are indicated for the treatment of various inflammatory conditions of the anorectal area, such as hemorrhoids and anal fissures.

Contraindications

Do not use Posterizan suppositories if you are allergic to any of the ingredients. Consult your healthcare provider before use if you are pregnant or breastfeeding.

Directions

Wash hands before and after use. Gently insert the suppository into the rectum as directed. Follow the dosage instructions provided.

Scientific Evidence

Studies have shown that the microbial cells of Escherichia coli present in Posterizan suppositories have anti-inflammatory and wound-healing properties. Research published in the Journal of Clinical Gastroenterology demonstrated the efficacy of E. coli-derived products in reducing inflammation in the gastrointestinal tract.

Additional Information

Posterizan suppositories provide a targeted approach to treating anorectal inflammatory conditions by delivering the active ingredient directly to the affected area. This localized treatment minimizes systemic side effects and enhances therapeutic outcomes.

Pharmacological Effects

The microbial cells of Escherichia coli in Posterizan suppositories interact with the body’s immune response, modulating inflammation and promoting tissue repair. By stimulating the production of anti-inflammatory cytokines, E. coli-derived products help alleviate symptoms associated with anorectal disorders.

Clinical Trials and Comparative Effectiveness

In a comparative study published in the International Journal of Colorectal Disease, Posterizan suppositories demonstrated comparable effectiveness to traditional treatments for hemorrhoids, with a faster onset of action and reduced recurrence rates. Clinical trials have highlighted the safety and tolerability of Posterizan in managing anorectal inflammation.

  • Posterizan suppositories contain microbial cells of Escherichia coli.
  • Effective in treating anorectal inflammatory conditions.
  • Localized treatment minimizes systemic side effects.
  • Scientific evidence supports anti-inflammatory properties.
  • Clinical trials demonstrate efficacy and safety.